Judge shuts down drugmakers’ 340B rebate plans, for now
A district court ruled HHS has the power to review drugmakers’ plans to pay hospitals rebates on 340B medications. But it left the door open to the controversial reforms.
A district court ruled HHS has the power to review drugmakers’ plans to pay hospitals rebates on 340B medications. But it left the door open to the controversial reforms.
